Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Clinical Trials in Missouri

299 recruiting clinical trials across 15 cities in Missouri (MO). Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
299
Total Trials
299
Recruiting Now
15
Cities
20
Conditions

Recruiting Trials in Missouri

Clinical trial data sourced from ClinicalTrials.gov. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT01209000

Nephrotic Syndrome Study Network

Minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), and Membranous nephropathy (MN), generate an enormous individual and societal financial burden, accounting...

Sponsor: University of MichiganEnrolling: 120020 locations
Minimal Change Disease (MCD)Membranous NephropathyGlomerulosclerosis, Focal Segmental
RECRUITINGPhase 1 / Phase 2NCT01659203

Proton or Photon RT for Retroperitoneal Sarcomas

This research study is a Phase I clinical trial. Phase I clinical trials test the safety of an investigational intervention. Phase I studies also try to define the appropriate...

Sponsor: Massachusetts General HospitalEnrolling: 8010 locations
Retroperitoneal Sarcoma
RECRUITINGPhase 3NCT01804686

A Long-term Extension Study of PCI-32765 (Ibrutinib)

The purpose of this study is to collect long-term safety and efficacy data for participants treated with ibrutinib and to provide ongoing access to ibrutinib for participants who...

Sponsor: Janssen Research & Development, LLCEnrolling: 70020 locations
Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaMantle Cell Lymphoma+4
RECRUITINGNCT01904851

Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes

XLPAD is an observational study designed to evaluate the effectiveness and use of stent and non-stent based therapies among PAD patients. The study will create a registry that...

Sponsor: Baylor Research InstituteEnrolling: 1400020 locations
Peripheral Arterial Disease
RECRUITINGNCT01915511

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

The Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry started recruiting in 2014 with the objective of studying Idiopathic Pulmonary Fibrosis. In 2018, the...

Sponsor: Duke UniversityEnrolling: 300020 locations
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
RECRUITINGNCT02432560

Safety and Durability of Sirolimus for Treatment of LAM

The MIDAS study aims to follow male and female LAM patients who are currently taking, have previously failed or been intolerant of, or may (at some time in the future) take mTOR...

Sponsor: University of CincinnatiEnrolling: 60020 locations
Lymphangioleiomyomatosis
RECRUITINGNCT02763683

Investigations of Dementia in Parkinson Disease

The purpose of this study is to use a brain imaging method called Pittsburgh B (PIB) Positron Emission Tomography (PET) and Vesicular Cholinergic Transport (VAT) PET to determine...

Sponsor: Washington University School of MedicineEnrolling: 3201 location
Parkinsons
RECRUITINGPhase 2NCT02932150

Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection

The goals of this clinical study are to compare the effectiveness, safety and tolerability of study drug, tenofovir alafenamide (TAF), versus placebo in teens and children with...

Sponsor: Gilead SciencesEnrolling: 15020 locations
Chronic Hepatitis B
RECRUITINGPhase 3NCT03016819

Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma...

THIS STUDY IS CURRENTLY RECRUITING PATIENTS WITH ALVEOLAR SOFT PART SARCOMA ONLY AND IS NO LONGER RECRUITING PATIENTS WITH SYNOVIAL SARCOMA OR LEIOMYOSARCOMA. This study...

Sponsor: Advenchen Laboratories, LLCEnrolling: 32520 locations
Alveolar Soft Part SarcomaLeiomyosarcomaSynovial Sarcoma+1
RECRUITINGPhase 1 / Phase 2NCT03128996

Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

This study is designed to estimate the efficacy and toxicity of familial HLA mismatched bone marrow transplants in patients with non-malignant disease who are less than 21 years...

Sponsor: Washington University School of MedicineEnrolling: 294 locations
Severe Sickle Cell DiseaseBone Marrow Failure SyndromesMetabolic Disorders+3
RECRUITINGNCT03141021

Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors

First, the investigators plan to use a retrospective analysis to determine the clinical landscape of neurofibromatosis (NF)1-associated malignant peripheral nerve sheath tumor...

Sponsor: Washington University School of MedicineEnrolling: 105013 locations
Malignant Peripheral Nerve Sheath Tumors
RECRUITINGPhase 2 / Phase 3NCT03373968

Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study

This is an open label, long-term safety, tolerability, and efficacy study of GIVINOSTAT in all DMD (Duchenne's muscular dystrophy) patients who have been previously treated in one...

Sponsor: ItalfarmacoEnrolling: 20620 locations
Duchenne Muscular Dystrophy
RECRUITINGNCT03482245

The Role of Circadian Clock Proteins in Innate and Adaptive Immunity

Our data suggest that modulating the characteristics of light carries the potential to modify the host response to injury and critical illness and thus, improve outcome. The...

Sponsor: Washington University School of MedicineEnrolling: 1441 location
PneumoniaNecrotizing Soft Tissue InfectionIntraabdominal Infections+1
RECRUITINGEarly Phase 1NCT03492762

PET Imaging CCR2 in Lung Inflammation

The primary objective of this study is to assess the lung distribution of the Positron Emission Tomography (PET) imaging radiotracer Cu-DOTA-ECL1i, which binds to the specific...

Sponsor: Washington University School of MedicineEnrolling: 1101 location
Lung Inflammation
RECRUITINGNCT03507257

Longitudinal Early-onset Alzheimer's Disease Study Protocol

The Longitudinal Early-onset Alzheimer's Disease Study (LEADS) is a non-randomized, natural history, non-treatment study designed to look at disease progression in individuals...

Sponsor: Indiana UniversityEnrolling: 85020 locations
Early Onset Alzheimer DiseaseAlzheimer DiseaseMild Cognitive Impairment
RECRUITINGPhase 1 / Phase 2NCT03516708

Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer

The purpose of this research study is to evaluate epacadostat when given with routine radiation therapy and chemotherapy (capecitabine and oxaliplatin) to treat rectal cancer...

Sponsor: Washington University School of MedicineEnrolling: 494 locations
Rectal Cancer
RECRUITINGPhase 3NCT04047628

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

This is a multi-center prospective rater-masked (blinded) randomized controlled trial of 156 participants, comparing the treatment strategy of Autologous Hematopoietic Stem Cell...

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)Enrolling: 15620 locations
Relapsing Multiple SclerosisRelapsing Remitting Multiple SclerosisSecondary Progressive Multiple Sclerosis
RECRUITINGPhase 1 / Phase 2NCT04094610

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Phase 1 will evaluate the safety and tolerability at different dose levels of repotrectinib in pediatric and young adult subjects with advanced or metastatic malignancies...

Sponsor: Turning Point Therapeutics, Inc.Enrolling: 7520 locations
Locally Advanced Solid TumorsMetastatic Solid TumorsLymphoma+1
RECRUITINGPhase 4NCT04160000

Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure

Heart failure (HF) with preserved left ventricular function (pEF) is difficult clinical syndrome to treat effectively with few evidence based therapies. Atrial fibrillation (AF)...

Sponsor: Electrophysiology Research FoundationEnrolling: 3609 locations
Atrial FibrillationHeart FailureDiastolic Heart Failure
RECRUITINGNCT04165109

Trial-Ready Cohort-Down Syndrome (TRC-DS)

The purpose of the Trial-Ready Cohort - Down Syndrome (TRC-DS) is to enroll 120 healthy adults with Down syndrome (DS), between the ages of 25-55, into a trial ready cohort (TRC),...

Sponsor: University of Southern CaliforniaEnrolling: 55020 locations
Down SyndromeAlzheimer DiseaseDementia
RECRUITINGNCT04202341

Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

Long-term, multicenter, multinational, observational, registry of patients with gMG that is designed to collect data on clinical outcomes and safety in patients prescribed Alexion...

Sponsor: Alexion Pharmaceuticals, Inc.Enrolling: 50020 locations
Generalized Myasthenia Gravis
RECRUITINGNCT04363684

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) represents the formalized integration of ARTFL (U54 NS092089; funded through 2019) and LEFFTDS (U01 AG045390;...

Sponsor: Mayo ClinicEnrolling: 210020 locations
Frontotemporal Lobar Degeneration (FTLD)Progressive Supranuclear Palsy (PSP)Corticobasal Degeneration (CBD)+11
RECRUITINGPhase 4NCT04373317

Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis

Patients with Parkinson's disease (PD) sometimes experience symptoms affecting their movement, such as slowness, tremor, stiffness, and balance or walking problems. Many patients...

Sponsor: VA Office of Research and DevelopmentEnrolling: 35820 locations
Parkinson's Disease Psychosis
RECRUITINGNCT04406818

Metabolic and Hemodynamic Reserve in Pediatric SCA

The purpose of this research study is to better understand how blood flow and metabolism change can influence brain development in the early decades of life. SCA participants and...

Sponsor: Washington University School of MedicineEnrolling: 1201 location
Child, OnlyBrain DiseasesSickle Cell Disease+1
RECRUITINGNCT04496687

International Spontaneous Coronary Artery Dissection (SCAD) "iSCAD" Registry

The aim of "iSCAD," the International Spontaneous Coronary Artery Dissection (SCAD) Registry, is to serve as an internationally collaborative, multicenter registry coordinated by...

Sponsor: SCAD AllianceEnrolling: 100020 locations
Spontaneous Coronary Artery Dissection
RECRUITINGNCT04509050

Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children

This is a two-part, multi-center, prospective longitudinal, exploratory study of highly effective cystic fibrosis transmembrane conductance regulator (CFTR) modulators and their...

Sponsor: Sonya HeltsheEnrolling: 21020 locations
Cystic Fibrosis
RECRUITINGPhase 2NCT04554914

A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases

The purpose of this study is to assess the efficacy and safety of tabelecleucel in participants with EBV-associated diseases.

Sponsor: Pierre Fabre MedicamentEnrolling: 19020 locations
Epstein-Barr Virus (EBV)-Associated DiseasesEBV+ Lymphoproliferative Disease With Primary Immunodeficiency (EBV+ PID LPD)EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (EBV+ AID LPD)+8
RECRUITINGNCT04579120

Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)

To identify factors that signal the transition from asymptomatic (preclinical) to symptomatic Alzheimer disease (AD).

Sponsor: Tammie L. S. Benzinger, MD, PhDEnrolling: 6501 location
Alzheimer Disease
RECRUITINGNCT04592445

Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF

The purpose of this clinical study is to evaluate the safety and early effectiveness of a catheter-based procedure that treats a nerve called the right greater splanchnic nerve....

Sponsor: Axon Therapies, INC.Enrolling: 15020 locations
Heart Failure With Preserved Ejection Fraction (HFpEF
RECRUITINGPhase 1NCT04626674

A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in...

This is an open-label gene transfer therapy study evaluating the safety of and expression from delandistrogene moxeparvovec in participants with DMD. The maximum participant...

Sponsor: Sarepta Therapeutics, Inc.Enrolling: 837 locations
Muscular Dystrophy, Duchenne

Showing 30 of 299 trials in Missouri. Search all trials

Browse Trials by State

Frequently Asked Questions

There are currently 299 clinical trials actively recruiting participants in Missouri. These span all phases from early-stage Phase 1 to late-stage Phase 3 trials, across 20+ conditions.

The top conditions with recruiting trials in Missouri include Alzheimer Disease, Amyotrophic Lateral Sclerosis, Colorectal Cancer, Ovarian Cancer, Sickle Cell Disease. Each has multiple active trials across research centers in the state.

Major trial sites in Missouri include St Louis, Kansas City, Columbia, Saint Charles, Springfield. Most large academic medical centers and research hospitals serve as trial sites.

Review the trial listings on this page and check the eligibility criteria — we translate them into plain English. When you find a trial that fits, talk to your doctor about whether it's right for you, then contact the trial team directly using the information on the trial page.

Sources: ClinicalTrials.gov
Last updated:

Trial data sourced from the ClinicalTrials.gov API. Location data reflects registered trial sites. This site does not provide medical advice.